These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 14702272)

  • 21. Tardive dyskinesia due to aripiprazole: report of 2 cases.
    Lungu C; Aia PG; Shih LC; Esper CD; Factor SA; Tarsy D
    J Clin Psychopharmacol; 2009 Apr; 29(2):185-6. PubMed ID: 19512985
    [No Abstract]   [Full Text] [Related]  

  • 22. Tardive dyskinesia in the era of typical and atypical antipsychotics. Part 2: Incidence and management strategies in patients with schizophrenia.
    Margolese HC; Chouinard G; Kolivakis TT; Beauclair L; Miller R; Annable L
    Can J Psychiatry; 2005 Oct; 50(11):703-14. PubMed ID: 16363464
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Ziprasidone-induced galactorrhea: a case report.
    Kopecek M; Bares M; Mohr P
    Neuro Endocrinol Lett; 2005 Feb; 26(1):69-70. PubMed ID: 15726024
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Acute urinary retention associated with selective serotonin reuptake inhibitors and ziprasidone.
    Chung AK; Chua SE
    J Clin Psychopharmacol; 2007 Oct; 27(5):517-9. PubMed ID: 17873690
    [No Abstract]   [Full Text] [Related]  

  • 25. Aripiprazole-induced improvement in tardive dyskinesia.
    Duggal HS
    Can J Psychiatry; 2003 Dec; 48(11):771-2. PubMed ID: 14733461
    [No Abstract]   [Full Text] [Related]  

  • 26. Aripiprazole-induced tardive dyskinesia: the role of tamoxifen.
    Evcimen YA; Evcimen H; Holland J
    Am J Psychiatry; 2007 Sep; 164(9):1436-7. PubMed ID: 17728431
    [No Abstract]   [Full Text] [Related]  

  • 27. Atypical antipsychotic withdrawal dyskinesia in 4 patients with mood disorders.
    Urbano M; Spiegel D; Rai A
    J Clin Psychopharmacol; 2007 Dec; 27(6):705-7. PubMed ID: 18004142
    [No Abstract]   [Full Text] [Related]  

  • 28. Tardive dyskinesia.
    Tarsy D; Baldessarini RJ
    Annu Rev Med; 1984; 35():605-23. PubMed ID: 6144288
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Tardive dystonia due to aripiprazole use in a neuroleptic-naive patient.
    Friedman JH
    J Clin Psychiatry; 2010 May; 71(5):652-3. PubMed ID: 20492857
    [No Abstract]   [Full Text] [Related]  

  • 30. Risk for adverse events and discontinuation due to adverse events of ziprasidone monotherapy relative to placebo in the acute treatment of bipolar depression, mania, and schizophrenia.
    Gao K; Pappadopulos E; Karayal ON; Kolluri S; Calabrese JR
    J Clin Psychopharmacol; 2013 Jun; 33(3):425-31. PubMed ID: 23609405
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Ziprasidone-induced tardive laryngeal dystonia: a case report.
    Tsai CS; Lee Y; Chang YY; Lin PY
    Gen Hosp Psychiatry; 2008; 30(3):277-9. PubMed ID: 18433661
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Hypomania induced by Ziprasidone].
    Cremonese E; Garrido R
    Braz J Psychiatry; 2004 Mar; 26(1):67. PubMed ID: 15057844
    [No Abstract]   [Full Text] [Related]  

  • 33. Comparison of severe and mild tardive dyskinesia: implications for etiology.
    Gardos G; Cole JO; Schniebolk S; Salomon M
    J Clin Psychiatry; 1987 Sep; 48(9):359-62. PubMed ID: 2887550
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Tardive dystonic symptoms associated with aripiprazole treatment.
    Lim HK; Pae CU; Lee C; Lee CU
    Prog Neuropsychopharmacol Biol Psychiatry; 2008 Feb; 32(2):589-90. PubMed ID: 18053627
    [No Abstract]   [Full Text] [Related]  

  • 35. Rare presentation of tardive dyskinesia.
    Cavallaro R; Smeraldi E
    Am J Psychiatry; 1992 Aug; 149(8):1115. PubMed ID: 1353318
    [No Abstract]   [Full Text] [Related]  

  • 36. FDA advisers wary of expanding quetiapine use: clinicians air concerns about metabolic effects, tardive dyskinesia.
    Traynor K
    Am J Health Syst Pharm; 2009 May; 66(10):880, 882. PubMed ID: 19420301
    [No Abstract]   [Full Text] [Related]  

  • 37. Factors in the development of severe forms of tardive dyskinesia.
    Yassa R; Nair NP; Iskander H; Schwartz G
    Am J Psychiatry; 1990 Sep; 147(9):1156-63. PubMed ID: 1974745
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Ziprasidone-related oculogyric crisis in an adult.
    Viana Bde M; Prais HA; Camargos ST; Cardoso FE
    Clin Neurol Neurosurg; 2009 Dec; 111(10):883-5. PubMed ID: 19717224
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Tardive dyskinesia with special emphasis on tardive dyskinesia caused by neuroleptics].
    Preradović M; Ilić T; Bjelica N
    Vojnosanit Pregl; 1996; 53(6):519-26. PubMed ID: 9229972
    [No Abstract]   [Full Text] [Related]  

  • 40. Duloxetine-related tardive dystonia and tardive dyskinesia: a case report.
    Chen PY; Lin PY; Tien SC; Chang YY; Lee Y
    Gen Hosp Psychiatry; 2010; 32(6):646.e9-646.e11. PubMed ID: 21112461
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.